FDA Drug Application (202217) for PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL by NOVEL LABS INC

Back to FDA Applications sponsored by NOVEL LABS INC

Application Number202217
Product Number001
FormFOR SOLUTION, TABLET, DELAYED RELEASE;ORAL
Dosage5MG,N/A;N/A,210GM;N/A,0.74GM;N/A,2.86GM;N/A,5.6GM
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL
Active IngredientBISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE

Active IngredientCount
List of drugs with Active Ingredient BISACODYL3
List of drugs with Active Ingredient POLYETHYLENE GLYCOL 335028
List of drugs with Active Ingredient POTASSIUM CHLORIDE279
List of drugs with Active Ingredient SODIUM BICARBONATE53
List of drugs with Active Ingredient SODIUM CHLORIDE352


Back to FDA Applications sponsored by NOVEL LABS INC